Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: James Perry who wrote (441)	9/18/1998 1:07:00 AM
From: John Zwiener	Read Replies (1) \| Respond to of 1025

James, it looks like you were typing at the same time I was. The new test as I would understand it, would detect a "marker" for activation or suppression of a gene. All cells have various genes going at any particular time to make things the cell needs, or in disease, what it doesn't need, or it fails to make what it needs. In a test, cells will have a certain activity. Add a compound and maybe the activity of a diseased cell will change on a genetic level compared to the healthy situation. The ability to detect this reliably on the most minute scale is a breakthrough, as we have discussed before. This is conjecture since I only have the news release for info, but this is something I have always thought was the true potential of Igen. It's nice to see the company may think so also, and probably more so than I realize, since they often surprise me.